Graves’ Disease treatment with radioiodine (131I) 10 mCi: clinical experience of a central hospital

https://doi.org/10.26497/ao180065 1646-3439/© 2019 Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo. Publicado por Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo. Este é um artigo Open Access sob uma licença CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/). * Autor Correspondente / Corresponding Author. E-Mail: anafgmartins@gmail.com (Ana Martins) Av. Prof. Egas Moniz, 1649-035 Lisboa Introduction: The aim of our study was to determine the effi cacy of 10 mCi fi xed-dose regimen of radioiodine (131I) in the treatment of Graves’ hyperthyroidism and to identify potential cure predictors. Material and Methods: We audited the outcome of Graves’ disease adult patients followed at the outpatient endocrine department who performed a fi rst 10 mCi fi xed-dose regimen between 2008 and 2015. T student and Mann-Whitney tests were used to compare continuous variables normally and non-normally distributed, respectively. Logistic regression was used to determine which factors